Leerink Swann Starts Achillion Pharmaceuticals (ACHN) at Outperform; Attractive Emerging HCV Portfolio
Tweet Send to a Friend
Leerink Swann initiates coverage on Achillion Pharmaceuticals (NASDAQ: ACHN) with a Outperform. PT $10.
Leerink analyst says, "We believe that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink analyst says, "We believe that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
